Home › Compare › NVTAQ vs SPHD

NVTAQ vs SPHD: Dividend Comparison 2026

NVTAQ yields 666666.67% · SPHD yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVTAQ wins by $8.275235618773884e+34M in total portfolio value
10 years
NVTAQ
NVTAQ
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full NVTAQ calculator →
SPHD
SPHD
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full SPHD calculator →

Portfolio growth — NVTAQ vs SPHD

📍 NVTAQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVTAQSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVTAQ + SPHD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NVTAQ pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVTAQ
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
SPHD
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, NVTAQ beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVTAQ + SPHD for your $10,000?

NVTAQ: 50%SPHD: 50%
100% SPHD50/50100% NVTAQ
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SPHD right now

NVTAQ
Analyst Ratings
3
Buy
5
Hold
4
Sell
Consensus: Hold
Altman Z
-23.5
Piotroski
4/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVTAQ buys
0
SPHD buys
0
No recent congressional trades found for NVTAQ or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVTAQSPHD
Forward yield666666.67% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$8.275235618773884e+34M$28.0K ✓
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$8.275075881065991e+34M ✓$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NVTAQ vs SPHD ($10,000, DRIP)

YearNVTAQ PortfolioNVTAQ Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,120$420.00+$66.67M → NVTAQ
2$415,506,651,117$415,435,306,334.37$12,357$458.31+$415506.64M → NVTAQ
3$2,419,908,598,386,268$2,419,464,006,269,573.00$13,721$499.76+$2419908598.37M → NVTAQ
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$15,227$544.58+$13171697643084.44M → NVTAQ
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$16,885$593.02+$67004927492790120.00M → NVTAQ
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$18,713$645.34+$318562277003514871808.00M → NVTAQ
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$20,724$701.81+$1.415484168853553e+24M → NVTAQ
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$22,938$762.73+$5.878130573362507e+27M → NVTAQ
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$25,372$828.41+$2.2813793009840744e+31M → NVTAQ
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$28,047$899.19+$8.275235618773884e+34M → NVTAQ

NVTAQ vs SPHD: Complete Analysis 2026

NVTAQ — Stock

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Full NVTAQ Calculator →

SPHD — ETF

SPHD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPHD shares.

Full SPHD Calculator →
📬

Get this NVTAQ vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVTAQ vs SCHDNVTAQ vs JEPINVTAQ vs ONVTAQ vs KONVTAQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.